Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts (Q46661656)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

Herman Waldmann

4

object named as

Waldmann H

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

3

object named as

Hale G

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

author name string

Novitzky N

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

Thomas V

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

36

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

675-682

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Infectious complications following T-cell depleted hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell se

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell tra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

21 January 2018

Allogeneic myeloablative transplantation for patients aged 50 years and over

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for early mortality in allogeneic bone marrow transplantation. A multivariate analysis on 174 leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

The CAMPATH-1 antigen (CDw52)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

EX VIVO DEPLETION OF T CELLS FROM BONE MARROW GRAFTS WITH CAMPATH-1 IN ACUTE LEUKEMIA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphocytes for relapsing patients with chronic myeloid leukemia: a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Manufacture and quality control of CAMPATH-1 antibodies for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

IMMUNE RECONSTITUTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION DEPLETED OF T CELLS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of CAMPATH-1H in BMT patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell depletion with Campath-1H 'in the bag' for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705119

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705119

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16113675

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46661656&oldid=2208006349"